Martin Höglund Selected Research

Martin Höglund Research Topics

Disease

14	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 11/2010
13	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2022 - 08/2002
13	Neoplasms (Cancer) 01/2020 - 07/2006
12	Leukemia 07/2021 - 10/2003
6	Lymphoma (Lymphomas) 11/2022 - 06/2002
5	Hematologic Neoplasms (Hematological Malignancy) 01/2020 - 05/2003
4	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 06/2020 - 01/2006
2	Inflammation (Inflammations) 11/2022 - 01/2020
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 09/2011
2	Myocardial Infarction 01/2022 - 01/2016
2	Cardiovascular Diseases (Cardiovascular Disease) 02/2021 - 06/2020
2	Acute Promyelocytic Leukemia 10/2017 - 04/2012
2	Hematologic Diseases (Blood Diseases) 03/2015 - 05/2013
2	Ovarian Neoplasms (Ovarian Cancer) 06/2012 - 03/2012
2	Philadelphia Chromosome 08/2008 - 09/2006
2	Multiple Myeloma 06/2005 - 10/2003
1	Pleural Effusion (Pleural Effusions) 01/2022
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2022
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2022
1	Sepsis (Septicemia) 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Heart Failure 01/2022
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 02/2021
1	Cardiotoxicity 02/2021
1	Disease Progression 01/2021
1	Residual Neoplasm 01/2021
1	Pathologic Complete Response 01/2021
1	Peptic Ulcer (Peptic Ulcers) 01/2020
1	Gastritis 01/2020
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2020
1	Dyspepsia (Indigestion) 01/2020
1	Ulcer 01/2020
1	Myeloid Leukemia (Leukemia, Myelocytic) 10/2017
1	Second Primary Neoplasms (Neoplasms, Second) 06/2015
1	Renal Cell Carcinoma (Grawitz Tumor) 05/2015
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 07/2014
1	Neutropenia 07/2014
1	Invasive Fungal Infections 07/2014
1	Reinfection 07/2013
1	Agammaglobulinemia (Hypogammaglobulinemia) 07/2013
1	Infections 07/2013
1	Human Influenza (Influenza) 05/2013

Drug/Important Bio-Agent (IBA)

11	Imatinib Mesylate (Gleevec)FDA Link 01/2022 - 08/2002
11	Tyrosine Kinase InhibitorsIBA 01/2022 - 11/2010
5	Dasatinib (BMS 354825)FDA Link 01/2022 - 08/2008
5	Pharmaceutical PreparationsIBA 01/2021 - 07/2006
4	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2020
2	Blood Proteins (Serum Proteins)IBA 11/2022 - 02/2021
2	Proteins (Proteins, Gene)FDA Link 11/2022 - 07/2021
2	nilotinib FDA Link 01/2022 - 01/2016
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 12/2014
2	NucleophosminIBA 01/2020 - 10/2019
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2019 - 01/2014
2	fludarabineIBA 12/2018 - 02/2016
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2018 - 02/2016
2	Rituximab (Mabthera)FDA Link 02/2016 - 01/2006
2	Immunoglobulin G (IgG)IBA 07/2013 - 06/2005
2	Phosphotransferases (Kinase)IBA 11/2010 - 08/2008
1	Biological ProductsIBA 11/2022
1	insulin receptor-related receptor (IRR)IBA 01/2022
1	Peroxidase (Myeloperoxidase)IBA 07/2021
1	LactoferrinIBA 07/2021
1	TroponinIBA 02/2021
1	pro-brain natriuretic peptide (1-76)IBA 02/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2021
1	ProteomeIBA 02/2021
1	Antineoplastic Agents (Antineoplastics)IBA 01/2021
1	Lenalidomide (CC 5013)FDA Link 01/2021
1	MyostatinIBA 06/2020
1	EnzymesIBA 01/2020
1	Proton Pump InhibitorsIBA 01/2020
1	thymidine kinase 1IBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2020
1	Chimeric Antigen ReceptorsIBA 12/2018
1	Biocompatible Materials (Biomaterials)IBA 02/2018
1	Antimalarials (Antimalarial Agents)IBA 12/2017
1	Quinacrine (Mepacrine)IBA 12/2017
1	Messenger RNA (mRNA)IBA 10/2017
1	IgA receptor (protein B)IBA 10/2017
1	Peptide Hydrolases (Proteases)FDA Link 01/2017
1	melflufenIBA 01/2017
1	AminopeptidasesIBA 01/2017
1	Alkylating AgentsIBA 01/2017
1	Telomerase (Telomerase Reverse Transcriptase)IBA 09/2015
1	Sunitinib (Sutent)FDA Link 05/2015
1	Fluconazole (Zonal)FDA LinkGeneric 07/2014
1	AzolesIBA 07/2014
1	posaconazole FDA Link 07/2014
1	Itraconazole (Sporanox)FDA LinkGeneric 07/2014
1	Intravenous Immunoglobulins (IVIG)FDA Link 07/2013
1	VaccinesIBA 05/2013

Therapy/Procedure

10	Therapeutics 02/2021 - 08/2002
7	Drug Therapy (Chemotherapy) 01/2021 - 09/2006
5	Stem Cell Transplantation 01/2021 - 09/2011
1	Genomic Medicine 01/2022
1	Treatment Delay 01/2021
1	Immunotherapy 05/2015
1	Palliative Care (Palliative Therapy) 03/2015
1	Induction Chemotherapy 07/2014